FUS pathology defines the majority of tau-and TDP-43-negative frontotemporal lobar degeneration

Hazel Urwin, Keith A. Josephs, Jonathan D. Rohrer, Ian R. MacKenzie, Manuela Neumann, Astrid Authier, Harro Seelaar, John C. Van Swieten, Jeremy M. Brown, Peter Johannsen, Jorgen E. Nielsen, Ida E. Holm, Dennis W. Dickson, Rosa Rademakers, Neill R. Graff-Radford, Joseph E. Parisi, Ronald C. Petersen, Kimmo J. Hatanpaa, Charles L. White, Myron F. WeinerFelix Geser, Vivianna M. Van Deerlin, John Q. Trojanowski, Bruce L. Miller, William W. Seeley, Julie Van Der Zee, Samir Kumar-Singh, Sebastiaan Engelborghs, Peter P. De Deyn, Christine Van Broeckhoven, Eileen H. Bigio, Han Xiang Deng, Glenda M. Halliday, Jillian J. Kril, David G. Munoz, David M. Mann, Stuart M. Pickering-Brown, Valerie Doodeman, Gary Adamson, Shabnam Ghazi-Noori, Elizabeth M.C. Fisher, Janice L. Holton, Tamas Revesz, Martin N. Rossor, John Collinge, Simon Mead, Adrian M. Isaacs

Research output: Contribution to journalArticle

171 Scopus citations

Fingerprint Dive into the research topics of 'FUS pathology defines the majority of tau-and TDP-43-negative frontotemporal lobar degeneration'. Together they form a unique fingerprint.

Medicine & Life Sciences